Alternatives to Stipple Bio

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered platform for understanding disease biology and accelerating drug discovery.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Developing engineered biologics to harness the immune system for disease treatment.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.